Exploring Renal Denervation for Patients With Uncontrolled Hypertension

Overview

This activity follows the recent publication of SCAI and NKF's Proceedings from Expert Consensus Roundtable on Renal Denervation Treatment for Use in Hypertension Patients, which outlines the possible role of renal denervation (RDN) as a therapeutic option to complement medical therapy and lifestyle interventions for patients with uncontrolled hypertension.

Content

Moderators: David E. Kandzari, MD, FSCAI and Raymond R. Townsend, MD
Panelist: Naomi Fisher, MD

• Introductions, David E. Kandzari, MD, FSCAI and Raymond R. Townsend, MD
• Looking at Gaps in Hypertensive Care, Eric Sesemsky, MD, FSCAI
• Examine the Data on Renal Denervation (RDN) in Patients With Uncontrolled Hypertension (HTN), Raymond R. Townsend, MD
• Patient Pathways for Hypertensive Care, Michael Bloch, MD
• Issue Around Disparities in Care, Keith Ferdinand, MD
• Panel Discussion

Faculty

	David E. Kandzari, MD, FSCAI SCAI Chair Piedmont Heart Institute		Raymond R. Townsend, MD NKF Chair University of Pennsylvania
	Eric Secemsky, MD, FSCAI SCAI Co-Chair Beth Israel Deaconess Medical Center		Michael Bloch, MD Renown Institute for Heart and Vascular Health, and University of Nevada, Reno School of Medicine
	Keith C. Ferdinand, MD Tulane University School of Medicine		Naomi D.L. Fisher, MD Harvard Medical School Brigham and Women’s Hospital

Acknowledgment of Commercial Support

This activity is supported by an unrestricted educational grant from Medtronic.
No in-kind commercial support was received.

Learning Objectives

At the end of this activity, participants will be able to:

Discuss the SCAI/NKF expert consensus roundtable proceedings document on renal denervation therapy for patients with uncontrolled hypertension.
Analyze data on renal denervation therapy in patients with uncontrolled hypertension.
Describe how improved primary care and advanced practice clinical education might impact hypertension management and referrals to specialty care.
Compare disparities in hypertension care across racial and socio-economic categories.

Accredited Continuing Education Information

Accreditation Statement
The Society for Cardiovascular Angiography and Interventions (SCAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
SCAI designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 medical knowledge MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Successful Completion
Watch the content and complete the evaluation to obtain credit.

Summary


Availability:	Retired


Cost:	FREE


Credit Offered:	No Credit Offered